Vitiligo-like lesions located over In-transit metastases of malignant melanoma as a clinical marker of complete response to pembrolizumab
| Autor: | Alba Hernández-García, María Pilar Sánchez-Salas, Esteban Padgett, Tamara Gracia-Cazaña |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Pathology
medicine.medical_specialty Side effect business.industry Incidence (epidemiology) Melanoma Dermatology General Medicine Pembrolizumab Vitiligo medicine.disease 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Immune system Medicine business Adverse effect Complete response |
| Zdroj: | Dermatology Online Journal. 25 |
| ISSN: | 1087-2108 |
| Popis: | Anti-programmed cell death (PD)-1 therapies in metastatic tumors have a high incidence of immune adverse events, including cutaneous manifestations such as vitiligo-like lesions. This side effect is associated with increased survival and it is a clinical marker of response to treatment. This case report is a graphic representation of the appearance of vitiligo-like lesions over in-transit metastases of malignant melanoma linked to a complete response to treatment with pembrolizumab. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|